Concepedia

Brian Booth

BB

Statistics

Publications

45

Citations

4.8K

H-Index

31

Active since

1990

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Bristol-Myers Squibb (United States)

United States Military Academy

Pharmaceutical Product Development (United States)

Brian Booth is an author at United States Food and Drug Administration specializing in pharmacology, medicine, and pharmacy.

Publications per year

1990–2020

45

Publications

45

Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays

C.T. Viswanathan, Surendra K. Bansal, Brian Booth et al. · Pharmaceutical Research · 2007 · 815 citations

Pharmacy, Biochemistry, Chemistry +16

Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays

C.T. Viswanathan, Surendra K. Bansal, Brian Booth et al. · The AAPS Journal · 2007 · 483 citations · Full text

Pharmacy, Chemistry, Analytical Chemistry +13

Vorinostat for Treatment of Cutaneous Manifestations of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Kun He et al. · Clinical Cancer Research · 2007 · 262 citations · Full text

Medicine, Hematology, Oncology +16

Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate

Michael H. Brave, Vicki Goodman, Edvardas Kaminskas et al. · Clinical Cancer Research · 2008 · 242 citations

Medicine, Hematology, Pharmacology +15

Approval Summary for Erlotinib for Treatment of Patients with Locally Advanced or Metastatic Non–Small Cell Lung Cancer after Failure of at Least One Prior Chemotherapy Regimen

John R. Johnson, Martin H. Cohen, Rajeshwari Sridhara et al. · Clinical Cancer Research · 2005 · 215 citations · Full text

Medicine, Oncology, Pharmacology +13

1–5 of 45